Click on the 'Court' button to view governing decisions issued by the Court and the 'Special Master' button to view governing Special Master decisions. The material on each page is grouped by subject matter. Use the buttons on each page to view decisions under the subject matter you are interested in.
Functional Impairment and Alternative Causation
March 29, 2024

The Special Master rejected a Retired NFL Football Player’s appeal of the Claims Administrator’s denial of his Supplemental Level 2.0 claim. The neurologist’s failure to show that the Player’s CDR scores were assigned due to cognitive loss, and not other factors, led to the Supplemental Claim’s denial. A diagnosing physician’s articulated consideration of confounding factors is typically sufficient to establish that a Player’s impairment is generally consistent with the Settlement’s requirements. Here however, the neurologist never discussed the Player’s depression and anxiety as possible contributors of his functional impairment, despite multiple inquiries. Both because the evidence of the Player’s functional loss was partially inconsistent with the required showing under the injury definitions, and because his physician did not attempt to show that it resulted from cognitive loss, as opposed to mental health and other factors, the Special Master found that the Player did not offer clear and convincing evidence of error in the denial.


Alzheimer's Disease Diagnostic Criteria
March 15, 2024

A Retired NFL Football Player appealed the Claims Administrator’s denial of his Alzheimer’s Disease claim, arguing that the AAPLC and the Claims Administrator erred in concluding that the Player’s MoCA scores (to detect mild cognitive impairment and dementia), depression and migraine symptoms, and biomarker testing intertwined to contraindicate Alzheimer’s Disease. The Special Master denied the appeal after concluding that the non-linear trajectory of the Player’s MoCA score, and the absence of biomarkers, combined to support the Claims Administrator's determination. The Special Master further concluded that use of biomarkers as probative, not dispositive, evidence in diagnosing Alzheimer's is consistent with the DSM-5 definition and thus the Settlement Agreement, and that the Claims Administrator is empowered to make sure that Diagnosing Physicians practices in using biomarkers is reasonably consistent.


Validity Testing and Deference
February 14, 2024
The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 2 Neurocognitive Impairment Monetary Award on the grounds of invalid neuropsychological testing. The NFL Parties asserted that despite the neuropsychologist’s articulated reasoning, his determinations were "clearly erroneous" and not entitled to deference. The clearly erroneous bar for overriding a clinician’s articulated reasoning is very high and his flaws would need to be so basic and foundational as to render his determinations unreasonable. At the Special Master’s request, an AAP Consultant ("AAPC") reviewed the claim and determined that the neuropsychologist’s validity analysis resulted from a reasonably determined medical judgment. The Special Master adopted the AAPC’s factual determination and denied the NFL Parties’ appeal.

Neuropsychological Testing
February 3, 2024

The Claims Administrator denied a Retired NFL Football Player’s Level 2 Neurocognitive Impairment claim on the grounds of missing valid neuropsychological test scores. The Settlement requires neuropsychological testing to establish a Diagnosis of Level 2 Neurocognitive Impairment and provides for waiver only when the diagnosing physician can certify that it is medically unnecessary because the Retired NFL Football player’s dementia is so severe. The diagnosing physician’s judgment must be "reasonably determined," meaning that it must be reasonable to have concluded that the testing would not generate valid results. Neither the neurologist’s contemporaneous report nor his later explanation illustrate impairment so severe that it would preclude the Player from completing neuropsychological testing. The Special Master denied the appeal but granted the Player a 6-month extension to request an Expanded BAP examination.


Validity Testing and Deference
January 26, 2024

The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 1.5 Neurocognitive Impairment Monetary Award, arguing that there was clear and convincing evidence that the Player’s neuropsychological testing was invalid. The NFL Parties’ burden of proof on appeal is high: "clear and convincing evidence" means it is highly probable or reasonably certain that there was an error. The Special Master asked for advice from the Appeals Advisory Panel who applied the Program’s "nested system of deference" regarding the validity testing. Because the neuropsychologist did not complete a Slick checklist, her validity analysis did not result from completely articulated reasoning, and thus the AAP conducted a thorough and independent review of the validity testing. The AAP advised that the testing did not reliably support the inference that the Player engaged in sufficient task engagement. Relying on that factual judgment, the Special Master found that there was clear and convincing evidence that the scoring was not valid, contrary to the Claims Administrator’s determination.


Parkinson's Disease Diagnosis Criteria
January 16, 2024
The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Parkinson’s Disease Monetary Award on the grounds that the Player did not meet the diagnostic criteria. Because the Amended Class Action Settlement description of the requirements for a Qualifying Diagnosis of Parkinson’s Disease while living is sparse, the Special Master enlisted a panel of AAP neurologists to describe their understanding of how to make a Qualifying Diagnosis of Parkinson’s Disease under the Settlement, and to evaluate the Player’s records given that consensus understanding. All members agreed that the appropriate criteria for a Qualifying Diagnosis of Parkinson’s Disease remain the Gelb criteria, which were the most widely used criteria in the United States at the time of the Settlement. All AAP members agreed that the MAF neurologist appropriately diagnosed the Player with Parkinson’s Disease and his medical records supported that diagnosis. The Special Master adopted the recommendation of the AAP neurologists to deny the NFL Parties’ appeal because it did not offer clear and convincing evidence that the Claims Administrator’s decision was in error.

Slick Analysis and Burden on Appeal
December 8, 2023
The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 2 Neurocognitive Impairment Monetary Award on the grounds of invalid neuropsychological testing. The NFL Parties argued that the examining neuropsychologist did not adequately account for the Player’s performance on several validity tests in his Slick analysis and was not entitled to any deference. For the NFL Parties to prevail on appeal after the Claims Administrator has accepted a Diagnosis as sufficiently supported by the medical records, they must show more than just occasional inadequacies in a neuropsychologist’s report. Their burden in such cases is to show that it is “highly probable or reasonably certain” that the clinician’s conclusions were erroneous. At the Special Master’s request, an AAP Consultant (“AAPC”) reviewed the claim and determined that although the neuropsychologist’s reasoning was not clearly articulated, his conclusions about the Player’s testing were not erroneous. The Special Master adopted the AAPC’s factual judgment and denied the NFL Parties’ appeal.

Generally Consistent Standard and Deference
November 30, 2023
The Claims Administrator denied a Retired NFL Football Player’s Level 1.5 Neurocognitive Impairment claim on the grounds that the neuropsychological testing was not generally consistent with the Settlement’s diagnostic criteria. The Player appealed, arguing that the Claims Administrator erred in not deferring to the articulated judgment of his medical providers. The Special Master convened the AAPC panel of neuropsychologists who determined that the clinician’s explanation for deviation from the BAP criteria was fully articulated. In applying the highly deferential "reasonably determined" standard of review, however, the AAPC concluded that the neuropsychologist’s explanation did not amount to a "reasonably determined medical judgement," and they could not conclude it sufficiently supported the Player’s diagnosis. Quoting Judge Brody who wrote that "deference is not the same thing as blind and automatic acceptance," the Special Master adopted the AAPC’s view and denied the Player’s appeal.

Functional Impairment and CDR Score
November 12, 2023
The Special Master denied a Retired NFL Football Player’s appeal of the Claim Administrator’s determination that the Player was entitled to a Level 1.5 Neurocognitive Impairment Award, instead of the Level 2 Neurocognitive Impairment Qualifying Diagnosis that he asserted. The diagnosing physician’s thoughtful report rested on statements by the Player and his wife, which were refuted by the record as it later developed through an audit of the claim. The audit uncovered that the Player had significant job responsibilities at the time of the Qualifying Diagnosis and for two years after it was rendered. These responsibilities were inconsistent with the diagnosing physician’s CDR score of 2.0 in the area of Community Affairs. That score required the Player to have "no pretense of independent function outside the home."

Neuropsychological Testing
November 11, 2023
The Claims Administrator denied a Retired NFL Football Player’s Level 2 Neurocognitive Impairment claim because of Qualifying Diagnosis lacked valid neuropsychological testing. On appeal, the Player argued that his impairment was so severe as to render neuropsychological testing unnecessary under the Settlement. Here, the Player completed a neuropsychological evaluation, which rendered invalid test results that the diagnosing physician chose to omit, claiming that the Player was too impaired to complete valid testing because of the severity of his functional impairments. The Special Master found because the diagnosing physician offered neither an coherent explanation of why the players' impairment was so severe as to not permit testing, nor an adequate rationale for setting aside the testing entirely, the Claims Administrator correctly determined that the Player’s claim must fail based on the absence of valid test scores to support it.

Functional Impairment
October 21, 2023
The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player sufficiently demonstrated functional impairment generally consistent with a Qualifying Diagnosis of Level 2 Neurocognitive Impairment. They argued that the MAF Physician considered a CDR worksheet completed by the Player’s wife instead of completing the worksheet himself, failed to offer any explanation for his assigned CDR scores and failed to consider if the Player’s functional impairment was due to some other condition. The Special Master acknowledged that it was not best practice for someone other than the MAF Physician to complete the CDR worksheet, however, in this instance it was not disqualifying because the MAF Physician conducted an in-person interview with the Player’s wife before providing his own assessment of the Player’s level of functional impairment and relied on other factors in addition to the CDR worksheet for his CDR conclusion. The Special Master also recognized that providing explanations for CDR scores is best practice, but where a physician fails to comply, and there is evidence in the claim record to suggest that the CDR scores are valid, the failure to comply cannot itself serve as clear and convincing evidence of error in determining a Player’s functional impairment, though it will affect the degree of deference that such scoring merits. In denying the appeal, the Special Master also found that the diagnosing physician determined that the Player’s functional impairment was due to cognitive loss, and not something else, as the CDR scale requires.

Alzheimer's Disease Diagnosis
October 16, 2023
The NFL Parties raised multiple technical objections to the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Supplemental Claim Award for Alzheimer’s Disease. The Special Master noted that the appeal process is built around layered deference to expertise, and especially when front-line clinicians articulate their medical decisions with "care and fastidiousness," the reviewing process is unlikely to come to a contrary decision. Upon the Special Master’s request, the AAP considered the NFL Parties’ arguments that the MAF Physician did not exclude mixed etiologies of end-stage renal disease and dialysis as well as major depression and relied on flawed imaging to make the diagnosis. The AAP determined, using DSM-5 and the ICD-10, that the MAF Physician provided articulated justifications for key aspects of the Diagnosis, and that he met the standard of care. The Special Master deferred to that analysis and denied the NFL Parties’ appeal.

Validity Testing and Mental Illness
October 16, 2023

The Special Master denied the appeal of the NFL Parties who contended that the Retired NFL Football Player’s mental illness compromised his neurocognitive testing results.  The Settlement Agreement requires that the examining neuropsychologist consider a Player’s psychiatric condition and its relationship to his performance across the measured cognitive domains, just as an examining neurologist must consider its relationship to his functional impairment. The Special Master found that the effects of mental illness on a Player’s neuropsychological testing are not clear and convincing evidence of error when, as here, the neuropsychologist has accounted for those effects in her thorough and, according to the AAPC, reasonable analysis.


Diagnosis of Death with CTE
October 7, 2023

The Claims Administrator determined that the CTE claims of two Representative Claimants were untimely under Section 6.3(f) of the Amended Class Action Settlement Agreement because their Qualifying Diagnoses post-dated April 22, 2015. Section 6.3(f) requires that a Qualifying Diagnosis of Death with CTE be made through a post-mortem diagnosis made by a board-certified neuropathologist prior to the Final Approval Date (April 22, 2015) for deaths that occurred prior to the Final Approval Date. The Claimants appealed, arguing first that they satisfied the diagnostic deadline for a Qualifying Diagnosis of Death with CTE, because a "diagnosis" occurs at death. The Special Master found that a Diagnosis of Death with CTE occurs when a board-certified neuropathologist personally examines the decedent’s brain tissue and concludes that it is marked by CTE. Second, Claimants maintained that, even if the Amended Settlement Agreement’s deadline had passed, the unamended Settlement Agreement contained no such deadline. Looking at the plain language of the Unamended Settlement Agreement as well as extrinsic evidence, the Special Master concluded that the Unamended Settlement Agreement would have denied recovery for Death with CTE that preceded July 7, 2014, but which was diagnosed by examination of brain tissue after that date.


Alzheimer's Disease Diagnosis and Biomarker Testing
September 8, 2023

The Special Master denied the appeal of the NFL Parties who contended that biomarker testing definitively ruled out the Retired NFL Football Player’s Qualifying Diagnosis of Alzheimer’s Disease. The Appeal raised the issue of what diagnostic material the Settlement treats as conclusive for a Qualifying Diagnosis of Alzheimer’s Disease. The Injury Definition for Alzheimer’s Disease under the Settlement, based on the scientific consensus of 2015, advises against dispositive use of biomarker correlates of clinical manifestations of Alzheimer’s Disease and relies on the World Health Organization’s International Classification of Diseases 9th or 10th Edition (ICD-9 or ICD-10), or the definition of Neurocognitive Disorder due to probable Alzheimer’s Disease in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The Program’s expert neurologists confirmed that biomarkers are not required for a diagnosis under the Settlement’s definition and the ICD-10/DSM-5. The Special Master found that the Qualified MAF Physician made the Player’s Qualifying Diagnosis based on over ten years of provider documentation and multiple third party affidavits that met the clinical criteria for diagnosis under either the ICD-10 or the DSM-5. The absence of biomarkers of Alzheimer’s cannot be clear and convincing evidence that the Claims Administrator’s decision to grant an Award was in error.


Validity and Historical Testing
August 6, 2023

The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 1.5 Neurocognitive Impairment Monetary Award. The Player completed two sets of neuropsychological evaluations (2018 and 2019 testing) that the Claims Administrator rescored under the New Method. The revised scores from the 2018 testing reflected Level 1.5 Neurocognitive Impairment, however, the 2019 testing scores did not. The NFL Parties challenged the Player’s Award on the grounds that: (1) the Retired NFL Football Player’s 2018 neuropsychological testing was invalid; and (2) even if valid, the 2019 neuropsychological testing should invalidate it. At the Special Master’s request, an AAP Consultant reviewed the Claim and determined that there was not adequate evidence to prove invalidity. The NFL Parties argued that the improvement between the two sets of testing was inconsistent with the presence of true organic impairment. The AAPC found, however, that there was no broad pattern of improvement or decline in the Player’s testing from 2018 to 2019. Further, as explained in FAQ #109, the Settlement Program contemplates the use of neuropsychological testing completed more than a year before a Player’s neurological evaluation if the Claims Administrator approves its use by the Qualified MAF Physician to measure impairment. The Claims Administrator’s exercise of discretion under FAQ #109 was "not erroneous" because (1) the 2018 testing was performed while demographic corrections were permitted under the Settlement Agreement, and (2) this was the first and only use of the 2018 testing battery.


Validity Testing
July 14, 2023

The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 1.5 Neurocognitive Impairment Monetary Award on the grounds of invalid neuropsychological testing. According to the Special Master, the NFL Parties must show by clear and convincing evidence that the Player’s test data was not "a valid reflection of his optimal level of neurocognitive functioning," based on his performance on the nine Slick validity criteria. The NFL Parties asserted that he failed two Slick criteria (#1 and #7) and both the AAP Consultant and AAP Member who reviewed the claim agreed. The Special Master determined that no deference was due to the evaluating neuropsychologist because he provided no explanation or context with his Slick checklist. Thus, the AAP was to “thoroughly and independently” evaluate the file, however, the AAP panel members disagreed as to whether the failure of the two Slick criteria was sufficient to determine the evaluation invalid. The Special Master found that the disagreement itself indicated that the NFL Parties did not satisfy their burden of showing clear and convincing evidence that the Player is not entitled to an award, and denied the appeal.


Absence of Neuropsychological Testing
April 22, 2023

The Claims Administrator denied a Retired NFL Football Player’s Level 2 Neurocognitive Impairment claim on the grounds of missing valid neuropsychological test scores. The requirement for neuropsychological testing can be waived only for MAF diagnoses when the diagnosing physician can certify that it is medically unnecessary because the Player’s dementia is so severe. The Claims Administrator has an obligation to determine if the certification was reasonably determined, i.e., that it was reasonable to have concluded that the testing would not generate valid results. Invalid testing—whether indicating insufficient effort or malingering—does not demonstrate cognitive loss. Because the diagnosing physician offered neither an explanation of the Player’s invalid testing nor an adequate rationale for setting aside the testing entirely, the Special Master concluded that the Claims Administrator correctly determined that the Player’s claim must fail based on the absence of valid test scores to support it.


Validity Testing
April 17, 2023

The Special Master affirmed the Claims Administrator’s denial of a Retired NFL Football Player’s Level 1.5 Neurocognitive Impairment claim based on invalid validity testing. The Settlement requires each neuropsychological examiner to complete the Slick criteria checklist to determine whether the Player’s test data is a valid reflection of his optimal level of neurocognitive functioning. Seven of the nine Slick criteria were indicated for this Player, and therefore the examiner determined that no conclusion could be drawn about the Player’s cognitive impairment level. Despite the invalid performance validity measures, the MAF Physician certified a Diagnosis of Level 1.5 Neurocognitive Impairment. The Special Master determined that the MAF Physician’s reasoning for ignoring validity testing because it may not be as accurate when the level of cognitive impairment increases did not sufficiently address the discrepancies within the results.


Absence of Neuropsychological Testing
March 29, 2023

The Claims Administrator denied a Retired NFL Football Player’s Level 2 Neurocognitive Impairment claim based on the absence of neuropsychological testing. This requirement can only be waived when the diagnosing physician can certify that it is medically unnecessary because the Player’s dementia is so severe. The diagnosing physician’s explanation did not link his doubts about the Player’s inability to complete neuropsychological testing to the severity of his dementia, but instead cited the Player’s psychiatric issues, anger, and agitation. The Special Master found that the Player’s anger and agitation were not legitimate reasons to not attempt neuropsychological testing. The Special Master followed the AAPC’s expert medical evaluation and the entire file in concluding that the Player’s dementia was not so profound as to preclude neuropsychological testing, and determined that the Claims Administrator correctly decided that the diagnosing physician’s conclusion was not reasonably determined. The Player ultimately completed neuropsychological testing after the Claims Administrator’s denial and the neuropsychologist determined that the testing was invalid because the Player demonstrated inconsistent effort, not, as the Player argued, as support for the conclusion that the testing could not have been completed at all.


Validity Testing, External Evidence, and Functional Impairment
March 27, 2023

The NFL Parties and the Retired NFL Football Player appealed a Denial of a Level 2 Award. The appeals largely focus on the appropriateness of using evidence of function illustrated in the Player's social media that post-dates the Claim's submission in the Review process. That later-arriving evidence revealed a pattern of functional behavior inconsistent with the profound functional impairment the Player’s diagnosis required.

Based on this external evidence, and the absence of any attempt to isolate the role of cognitive loss as opposed to other factors, the Special Master, granting the NFL Parties’ appeal, concluded that the Player did not sufficiently demonstrate the requisite functional loss.

The Player’s appeal raised multiple issues regarding Claims Administration, but centered on the argument that validity must be fixed at the time of the Diagnosis. The Special Master found that the Settlement Agreement did not adopt a "reasonable doubt" standard for a finding of invalidity. And, regarding later-created evidence, the Special Master concluded that a plain reading of the Settlement Agreement permitted its use. In considering the social media evidence, the Special Master determined that, though the Settlement’s claims review process typically privileges evidence contemporaneous to the diagnosis, when later arriving information establishes a pattern of behavior inconsistent with the factual predicates of a diagnosis, the Claims Administrator has a duty to consider it. The Special Master concluded that due process applied to Claims Administration. But the External Evidence rules, adopted by the Claims Administrator in 2020, vindicate that interest, and no special rules for social media evidence are required. The Special Master denied the Player’s appeal, finding that the later-arriving pieces of evidence established that the testing was invalid.


Neuropsychological Testing and Validity
March 17, 2023

The Retired NFL Football Player appealed the Claim Administrator’s denial of his two claims for Level 2 Neurocognitive Impairment: a 2017 Pre-Effective Date Claim and a 2018 Post-Effective Date Claim. The 2017 Claim’s denial results from failures of both validity and insufficient functional impairment; the 2018 Claim’s denial focuses on functional impairment and the absence of neuropsychological testing without a reasonably articulated excuse. The Claims were based on two neurological assessments completed one month apart. In affirming the denial, the Special Master found that the Player’s two examinations were conducted in ways so inconsistent with the Settlement’s Injury definitions that they provided insufficient foundations for an award. One described invalid test scores; the other relied on those very exams to excuse a failure to administer additional testing.


Validity Testing
March 1, 2023
The Special Master affirmed the Claims Administrator’s denial of a Retired NFL Football Player’s Level 1.5 Neurocognitive Impairment claim based on invalid validity testing. The Special Master rejected the Player’s argument that the neuropsychologist was entitled to deference because she provided a well-reasoned and medically sound justification for considering his neuropsychological testing valid, despite suboptimal performance validity test scores. The Special Master reiterated his previous holding that a clinician’s conclusion that scores are not "suboptimal" is not entitled to deference when those scores indicate a "high likelihood of invalid performance" according to the Clinician’s Interpretation Guide. All three AAP Consultants reviewed the neuropsychologist’s analysis and confirmed that the Player did not meet the criteria for Level 1.5 or Level 2 Neurocognitive Impairment. The AAPC panel determined that the Player’s "worse than chance" scores on performance validity measures suggested deliberate underperformance rather than cognitive difficulties.

Stroke Offset
January 20, 2023
The Special Master denied the appeal of a Representative Claimant who contended that the Claims Administrator incorrectly applied the stroke offset to a Retired NFL Football Player’s Level 2 Neurocognitive Impairment claim. The Settlement provides that if a Retired NFL Football Player suffered a medically diagnosed stroke prior to a Qualifying Diagnosis, a 75% offset will be applied to his Monetary Award unless "the Settlement Class member demonstrates, by clear and convincing evidence, that the Qualifying Diagnosis was not causally related to the Stroke." The Representative Claimant argued that the Claims Administrator and AAP should have deferred to the primary care physician’s judgment that the Player’s stroke did not cause his neurocognitive impairment rather than that of the examining BAP neurologist and neuropsychologist who linked the stroke to his impairment. The Special Master has repeatedly emphasized the "fundamental presumption that the Claims Administrator – and by extension the AAP – should defer to the articulated medical judgments of examining clinicians and physicians." That deference applies to BAP providers who have expertise specific to the Settlement and the opportunity to apply that expertise in their examinations of the Player. The Special Master found that the Claims Administrator and AAP correctly and reasonably relied on the Player’s BAP examinations to apply the stroke offset.

Validity Testing
January 12, 2023

The Special Master affirmed the Claims Administrator’s denial of a Retired NFL Football Player’s Level 1.5 Neurocognitive Impairment claim based on invalid validity testing and insufficient information regarding functional impairments. The AAP and AAPC worked carefully through the BAP neuropsychologist’s analysis, which sought to explain away failure on two or more performance validity tests. The Settlement Agreement specifically indicates that such failures “may result in the Retired NFL Football Player’s test results being subjected to independent review, or result in a need for supplemental testing of the Retired NFL Football Player.” It was in service of that requirement that the AAP, AAPC, and the Claims Administrator assessed whether or not the Player’s testing represented the optimal level of his neurocognitive functioning and they determined that it did not.


AAP Review and Validity Testing
January 12, 2023
The Special Master denied the appeal of a Retired NFL Football Player’s Level 2 Neurocognitive Impairment claim. The Player argued that the Claims Administrator improperly referred his claim to the AAP, which he asserted is only permissible when there are conflicting BAP diagnoses. The District Court previously considered the Player’s argument and found that the Claims Administrator may request AAP review of a claim, regardless of whether there are conflicting diagnoses. The Special Master followed the Court’s decision in concluding that the Claims Administrator did not err by asking for AAP input. The Player also argued that his testing was valid and that the AAP Member who reviewed his claim ignored the testing results and the BAP neuropsychologist’s determination that he passed all Slick criteria. Flaws in the BAP neuropsychologist’s review of the Player’s claim illustrate why AAP review of BAP diagnoses is sometimes necessary to ensure diagnostic accuracy. The AAPC and an AAP Member both found that the Player’s neurocognitive assessment failed the Settlement’s validity criteria requirements, precluding him from meeting the Settlement criteria for Level 2 Neurocognitive Impairment.

Validity Testing
November 23, 2022
The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 1.5 Neurocognitive Impairment Monetary Award on the grounds of invalid neuropsychological testing. The NFL Parties argued that the Player’s testing was not "a valid reflection of his optimal level of neurocognitive functioning" and thus could not support his Qualifying Diagnosis. At the Special Master’s request, an AAP Consultant and AAP member reviewed the Claim and found that the testing was valid. The AAP Consultant determined that the standard that the NFL Parties applied of optimal performance differs from customary clinical practice and is "an unreasonable, even unattainable, standard." The Special Master denied the NFL Parties’ appeal, finding that the Settlement does not require that the Player be functioning at the absolute peak of his capabilities for his testing to be valid.

Date of Diagnosis
November 1, 2022

The Special Master denied the appeal of a Retired NFL Football Player who disputed the date of Diagnosis that the Claims Administrator used in calculating his Level 2 Neurocognitive Impairment Monetary Award. The issue on appeal was whether, under FAQ 101, the underlying medical records provided reliable evidence from which the Diagnosing Physician could conclude that the Qualifying Diagnosis existed earlier than the date of his personal examination in 2021. FAQ 101 requires the Claims Administrator to strictly scrutinize in the claims review process Qualifying Diagnoses that predate a Diagnosing Physician’s examination of a Player. The Special Master found that there was no clear and convincing evidence that the earlier Diagnosis date provided a medically sound and reliable basis to conclude that the Player suffered from Level 2 Neurocognitive Impairment prior to 2021.


Untimely Claim Package
October 10, 2022

The Claims Administrator denied a Representative Claimant’s claim because it fell outside the Settlement Agreement’s timing rules. Section 8.3(a)(i) of the Settlement Agreement requires Claims Packages to be submitted no more than two years from the date of Diagnosis (or from the date the Settlement Class Supplemental Notice was posted on the Settlement Website, whichever is later). That deadline may be extended to four years if the Claimant can show that substantial hardship precluded compliance with the two-year deadline. The Representative Claimant did not meet the two-year deadline and did not submit a hardship consideration request. He asserted that the Claims Administrator should have considered his claim submitted when his counsel sent the Claims Administrator an email requesting an opportunity to submit the Retired NFL Football Player’s claim for review posthumously, based on his medical records. The Special Master affirmed that the Settlement’s limitation period is tolled by the submission of a Claim Package, not a request for review.


Contemporaneous Records
August 6, 2022
The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 1.5 Monetary Award appeal, on the grounds that the Player’s Diagnosis was unsupported by contemporaneous records that reflected a sufficient degree of functional impairment. The Special Master found that the Claims Administrator correctly considered revisions that the Diagnosing Physician made to the Player’s CDR scores and Diagnosis within months of his original exam, after receiving the neuropsychologist’s testing results and in response to an inquiry from the Claims Administrator to resolve missing information. The revised Diagnosis sufficiently documented the rationale for CDR scores of 1 in the areas of Community Affairs, Home & Hobbies, and Personal Care to support Level 1.5 Neurocognitive Impairment, and therefore the Special Master denied the appeal.

Validity Testing and Functional Impairment
April 25, 2022

The Claims Administrator denied a Retired NFL Football Player’s Level 1.5 Neurocognitive Impairment claim on two grounds: criterion (ii) due to multiple validity concerns; and criterion (iii) because it was unclear to what extent the Player's functional decline was related to untreated major depression, headaches and insomnia rather than cognitive impairment.  According to the Program’s experts and even his own doctors, the Player’s testing did not offer valid estimates for any impairment level under the Settlement.  As to criterion (iii), the diagnosing neurologist neither provided a careful analysis of functional impairment in her original report nor did any supplemental analysis to support an appropriate finding. The Special Master determined that the Player had not offered clear and convincing evidence of error in the Claims Administrator’s findings.


Stroke Definition
April 25, 2022
The Claims Administrator granted a Retired NFL Football Player’s Level 2 Neurocognitive Impairment claim and applied the Stroke Offset, which reduced the Monetary Award by 75%, because the Player suffered two strokes before the date of his Qualifying Diagnosis. The Settlement provides that if a Player receives a Qualifying Diagnosis after suffering a medically diagnosed stroke, the 75% Stroke Offset will not apply “if the Settlement Class Member demonstrates, by clear and convincing evidence, that the Qualifying Diagnosis was not causally related to the Stroke.” The Special Master defined the issue on appeal to be whether the claimant offered sufficient evidence to produce a firm belief or conviction that the stroke did not cause the Qualifying Diagnosis. When reviewing whether the Stroke Offset should apply, an AAP Member’s task is to evaluate the sufficiency of the reasoned judgment of the diagnosing physician—not to offer their own, independent judgment as a substitute. The diagnosing physician, after conducting a careful examination of the Player, reviewing numerous other records, and providing a thoughtful explanation of his process and reasoning, concluded that the Stroke Offset should not apply. The AAP did not defer to that reasoned explanation. Because of this inappropriate level of scrutiny and more than sufficient proof that the Player suffered significant cognitive decline prior to his first stroke, the Special Master granted the Player’s appeal and directed the Claims Administrator to reissue the Monetary award without the 75% Stroke Offset.

Validity Testing
April 18, 2022

The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 1.5 Neurocognitive Impairment Monetary Award on the grounds of invalid neuropsychological testing and deference to the clinicians’ determination. At the Special Master’s request, the AAP Consultants met as a group to review this Claim and concluded that deferral to the clinicians’ determinations was not possible because their clinical judgment regarding validity was not well-reasoned. The consensus review by the AAP Consultants found the evidence overwhelming that the Player was not exerting adequate effort to perform well on testing; therefore, the test results and conclusion could not be considered valid. Accordingly, the Special Master determined that deference to the Player’s clinicians would violate the Settlement’s requirement that the Player’s diagnosis resulted from test scores that validly reflect his “optimal level of neurocognitive functioning” and granted the appeal.


Validity Testing
April 1, 2022

The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 1.5 Neurocognitive Impairment Monetary Award on the grounds of invalid neuropsychological testing. The Special Master acknowledged the NFL Parties’ assertions that the BAP Provider’s Slick analysis was not fully articulated and that his judgment could be set aside for lack of foundation because the Player’s test scores indicated a high likelihood of invalid performance.  However, two different AAP Consultants reviewed the validity of the Player’s neuropsychological test scores and thoroughly and independently assured themselves the criteria did not indicate invalid testing.  The Special Master deferred to their expert judgment and denied the appeal.


Qualifying Diagnoses Criteria
March 30, 2022
The Claims Administrator denied a Retired NFL Football Player’s Level 1.5 Neurocognitive Impairment claim because his diagnosing physician ultimately did not issue a Qualifying Diagnosis and the Player appealed. Qualifying Diagnoses of Level 1.5 Neurocognitive Impairment made outside of the BAP must be generally consistent with four diagnostic criteria. Under criterion ii, the diagnosing physician determined that the Player did not appear to meet criteria for impairment in two or more cognitive domains. Criterion (iii) requires evidence of a decline in functioning that is consistent with a Clinical Dementia Rating (”CDR”) score of 1.0 in three specific categories: Community Affairs, Home & Hobbies, and Personal Care.  The Player scored 0.0 in all three categories. The Special Master denied the appeal because the Player did not satisfy criterion (ii) or (iii) of the four diagnostic criteria needed for a Level 1.5 Neurocognitive Impairment Qualifying Diagnosis.

Eligible Seasons and Date of Diagnosis
March 21, 2022

The Special Master denied the appeal of a Retired NFL Football Player who disputed the total number of Eligible Seasons and the date of Diagnosis that the Claims Administrator used in calculating his Monetary Award. A Player injured in a preseason game and subsequently placed on the injured reserve list for that year does not qualify for an Eligible Season under the Settlement Agreement. The date of Diagnosis is ordinarily set by the diagnosing physician, at the point when he or she "has enough information and materials, including test results, to be able to render a medically sound and reliable judgment about the Player’s condition, the way a physician normally does in his or her clinical practice." Although the Retired NFL Football Player experienced delays trying to schedule a BAP exam, no Diagnosis resulted from that exam and he did not receive a Qualifying Diagnosis until his MAF Physician diagnosed him with Alzheimer’s Disease in 2021, so there was no earlier Diagnosis date to consider.


Validity Testing
March 21, 2022
The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 2.0 Neurocognitive Impairment Monetary Award on the grounds of invalid neuropsychological testing. Where the examining clinician fully articulated his or her judgment about validity, the Appeals Advisory Panel Consultant should determine whether the analysis was clearly erroneous. The Program’s medical experts, applying that standard, concluded the Player's test scores did not represent valid estimates of his optimal level of neurocognitive functioning. The Special Master therefore granted the Appeal.

Functional Impairment
March 11, 2022

The NFL Parties appealed the Claims Administrator’s determination that a Retired NFL Football Player was entitled to a Level 1.5 Monetary Award because the Player’s reported abilities were inconsistent with the functional impairment required of his diagnosis. For a Qualifying Diagnosis of Level 1.5 Neurocognitive Impairment, the Player must exhibit functional impairment generally consistent with the criteria set forth in the CDR scale category 1.0 in the areas of Community Affairs, Home & Hobbies, and Personal Care. The BAP neuropsychologist analysis, which had used a third-party affidavit to supplant rather than corroborate a CDR analysis, did not support the requisite functional impairment. During the appeal, the Player submitted additional medical reports from 2021 showing mild functional impairment, but those records were not probative of whether the Player was similarly afflicted in 2018. The Special Master therefore granted the Appeal.


Qualifying Diagnoses Criteria
January 25, 2022

To be paid through the Settlement, a Claimant must meet the specific requirements outlined for any of six “Qualifying Diagnoses.” In this case, there was documentation of the Retired NFL Football Player’s progressive cognitive decline, and unrebutted evidence that he suffered from CTE at the time of his death. But those diagnoses, and their supporting medical records, did not fit into the Settlement’s prescribed boxes for the claimed Qualifying Diagnosis of Level 1.5 Neurocognitive impairment, and therefore the Special Master agreed with the Claims Administrator’s denial of the claim.


Validity Testing and Functional Impairment
October 31, 2021
The Claims Administrator denied the Level 1.5 Neurocognitive Impairment claim because of failed performance validity assessments (criterion (ii)) and insufficient evidence of mild decline in functional impairment (criterion (iii)).  The Special Masters required that a member of the AAP, with assistance from an AAP Consultant, make an individualized assessment of the claim because it relied on an evaluation performed by a specific previously-audited neuropsychologist. Based on the AAP’s assessment of inconsistencies involving Slick validity criteria and inadequate evidence of functional decline due to cognitive impairment, the Claims Administrator concluded that criteria (ii) and (iii) were not fulfilled. In rejecting the Player’s appeal, the Special Master deferred to the findings of the AAP and AAP Consultant.

Neuropsychological Testing
September 23, 2021
The Claims Administrator denied the Level 2 Neurocognitive Impairment claim because of the lack of evidence to support the diagnosing physician’s determination that neuropsychological testing was unnecessary. As FAQ 363 explains, if the diagnosing physician indicates that neuropsychological testing is medically unnecessary because of the severity of the Player’s dementia, the Claims Administrator has the obligation to determine if that conclusion was "reasonably determined." In rejecting the Player’s appeal, the Special Master deferred to the AAP’s conclusion that the Player’s cognitive screening test results did not indicate a severity of impairment that would lead a diagnosing physician to reasonably conclude that further testing was medically unnecessary.

Functional Impairment/Cognitive Decline
September 7, 2021
The Claims Administrator denied the Level 2 Neurocognitive Impairment claim because the Player did not submit a valid assessment of neuropsychological impairment (criterion (ii)) and did not show sufficient evidence of impaired daily functioning (criterion (iii)). The Special Master overturned that decision. An AAP Consultant and the AAPLC reviewed the claim on appeal and agreed that criterion (ii) for a Qualifying Diagnosis of Level 2 Neurological Impairment was fulfilled under the exception that a neuropsychological evaluation was not necessary because of the severity of the dementia. The Special Master deferred to the independent experts’ analysis that the diagnosing physician’s conclusion that neurological testing was medically unnecessary was reasonably determined. The Special Master rejected the AAPLC’s adverse recommendation regarding criterion (iii), instead finding that the diagnosing physician’s articulated consideration of psychiatric symptoms in assessing his functional impairment, and the conclusion that the Player nevertheless has dementia, was generally consistent with what the Settlement requires.

Slick Analysis and Functional Impairment
July 1, 2021
The Claims Administrator denied this claim on multiple grounds, including unaddressed Slick validity criteria and an unclear and underdeveloped record regarding the Player’s daily cognitive functioning. The Special Master found that the neuropsychologist’s assessment fell well short of a thorough consideration of the claim’s inconsistencies and instances of potential invalidity and did not reflect an articulated judgment about the Slick criteria. The clinician also failed, to the extent feasible, to attempt to isolate the functional impairment due to cognitive loss alone and assign a CDR rating based solely on cognitive loss, as required by the Settlement.

Audit
June 3, 2021
The Claims Administrator denied the Player’s claim and during the pending appeal, the claim was placed into audit. The Claims Administrator provisionally found a potentially material piece of evidence to be fabricated, which led it to doubt the trustworthiness of a key source of information about the Player’s functional impairment. That source was subsequently excluded from the record so the appeal could move forward. However, the Settlement Program demands that its fiduciaries work efficiently to pay valid Claims: one of the Special Masters’ primary duties is to make sure that the documentation and evidence that they rely upon as custodians of the Monetary Award Fund is reliable. As a result, the Special Master ordered the Claims Administrator to reopen the audit and make findings about whether any of the Player’s statements and documentary submissions misrepresented or omitted material facts, and if any misrepresentations are found, what role the Player’s law firm had in such misrepresentations.

Functional Impairment
May 28, 2021
Relying on the review and recommendations of an AAPC and AAP Member, the Claims Administrator denied the Player’s claim for Level 1.5 Neurocognitive Impairment. The Claims Administrator comprehensively explained why the Player’s diagnosis was not generally consistent with the Settlement criteria for Level 1.5 Neurological Impairment, specifically criteria (ii) evidence of moderate to severe cognitive decline . . . in two or more cognitive domains and criteria (iii) functional impairment. As FAQ 113 makes clear, the Diagnosing Physician’s report is a key document in evaluating whether the Player has adequately come forward with evidence of his functional impairment. That report is supposed to pull together the Player’s medical history, relevant documents and the physician’s articulated judgment. The Special Master upheld the denial, concluding that the MAF Physician’s report and supplemental email concerning the Player’s functional impairment do not establish a CDR of 1, and thus cannot support an overall award of Level 1.5 Neurocognitive Impairment.

Slick Criteria and CDR Scoring
April 27, 2021
The AAP should defer to a clinician’s Slick-criteria-based analysis when it results from reasoning completely articulated in contemporaneous reports unless the analysis is clearly erroneous.  A Slick analysis is not clearly erroneous because a member of the AAP or the Claims Administrator disagrees with the conclusion that the neuropsychologist made. The Special Master deferred to the first AAP Consultant who reviewed the Slick analysis and found that it was cogent and addressed each relevant factor.  The Special Master also concluded that the Player’s CDR, along with his neuropsychological test results, indicate that he is eligible for benefits associated with a qualifying diagnosis of Level 1.5 Neurocognitive Impairment instead of Level 2 Neurocognitive Impairment that the Diagnosing Physician found.

Functional Impairment and Validity Testing
March 19, 2021
The Claims Administrator denied the claim on two grounds: retained functional impairment that “indicate[s] a higher level of functioning than would be generally consistent with the Settlement criteria for Level 2 Neurocognitive Impairment,” and invalid neuropsychological testing. The Special Master found that the absence of an informant interview, coupled with a documented history of depression and the Diagnosing Physician’s inadequate analysis of the relationship between it and the Player’s functional impairment left a gap that justified the denial. Regarding test validity, the neuropsychologist’s discussion of the majority of the Slick criteria was conclusory and the Special Master deferred to the AAP’s independent medical judgment that the Slick criteria indicated that the Player’s testing provided an invalid measure of his abilities.

Functional Impairment
March 10, 2021
The Special Master examined whether the claim was wrongly denied in part because of evidence of the nature of the Player’s driving. For a Qualifying Diagnosis of Level 2 Neurocognitive Impairment, the Settlement Agreement requires evidence of functional impairment generally consistent with a CDR 2 rating in Community Affairs, meaning that a Class Member has “[n]o pretense of independent function outside [the] home.” Nothing in the Agreement categorically states that a Level 2 Diagnosis is incompatible with continuing to drive. But the fact and extent of this retained functional ability is one of several factors that together help clinicians, including the AAP Members and Consultants, evaluate a Claim.  It was the AAP Consultant’s independent view that the Player’s retained ability to transport himself, his loved ones, and those he mentors on a daily basis is inconsistent with a CDR Score of 2 in Community Affairs. The Player disagreed with the weight that the AAP Consultant gave to this factor. But that disagreement about weighting, argued at length, is not clear and convincing evidence that the AAP’s judgment (which the Claims Administrator adopted) was wrong.  The Special Master also stressed that Counsel must take reasonable steps to verify the accuracy of Claims made in their filings, especially when relying on Claimants whose memory may be fading.

Validity Testing and Functional Impairment
February 16, 2021
Eight Retired NFL Football Players’ claims relied on evaluations performed by a neuropsychologist who the Claims Administrator recommended be disqualified after Audit. The Special Masters decided that the AAP must perform an independent review of this neuropsychologist’s claims, because the records "may involve a misrepresentation, omission, or concealment of material fact."  These eight claims largely rely on sparse assessments that fail to include necessary detail for the Qualifying Diagnoses they assert.

Deviation from BAP Criteria
January 23, 2021
The AAP determined that the test battery was not generally consistent with the BAP criteria. Though it is true that some test variables overlap, the AAP’s analysis is more individuated and focuses on the goals of the tests and their relationship to establishing a reliable and meaningful exam. As the AAP concluded, “no reasonable substitutes” exist for important parts of the Settlement’s evaluative exams, the doctor's methods did not provide internal indicia of validity in the way that the Settlement requires, and the doctor paid no attention to qualitative evidence of validity through the Slick criteria.

Validity Testing
January 15, 2021
The Retired NFL Football Player did not offer evidence generally consistent with a Level 2 Diagnosis.  The Player’s test scores were not valid: the Player failed the quantitative measures; the doctor’s Slick analysis was both cursory and incorrect; and the AAPLC appropriately determined that a more rigorous analysis would have qualitatively and additionally determined the Player’s testing to be unreliable.

Functional Impairment
December 15, 2020
Functional impairment remains a barrier to the Player’s recovery. The Denial notes problems in the process by which the CDR was performed, raises concerns about the Player’s retained function, and states that the doctor failed to explore alternative bases for the Player’s disabilities. The Player’s Appeal argues that the "record is replete with evidence showing that he has a CDR of at least 1.0." The Special Master concluded that the Player has not met his burden on Appeal. He has not shown clear error in the Claims Administrator’s analysis of his involvement in community affairs, and consequently has failed to rebut an important gap in the file.

Reasons in Notice of Denial
December 4, 2020
The Settlement Agreement requires the Claims Administrator to provide “the reasons for the adverse determination” in the Notice. The Special Master concluded that the Notice of Denial is ambiguous as to whether this Player’s functional impairment was a reason for the adverse determination. On remand, the Claims Administrator shall evaluate whether the Player has provided documentation of functional impairment that is generally consistent with a Level 1.5 Diagnosis. It may then either issue an Award, provide the Player an opportunity to remedy any deficiencies it finds, or re-issue a revised Notice of Denial of the Player’s Claim.

Substance Use
December 2, 2020
The Player regularly consumed marijuana, including on the morning of his neuropsychological evaluation. Without further detail on the dosage and frequency of use of the substance, and without further detail on whether and how the neurologist considered the use of marijuana in her ultimate Diagnosis, the record is incomplete. The Claims Administrator may solicit from the doctor the dosing information and frequency of marijuana use. The doctor may also submit an analysis of why a Diagnosis of Level 1.5 Neurocognitive Impairment is appropriate despite the potential impacts marijuana may have had on neuro exam and on his daily cognitive functioning, as articulated in the CDR.

Deviation from BAP Criteria
October 28, 2020
The AAP determined that the test battery was not generally consistent with the BAP criteria for six similarly situated claimants and this decision is representative of the six issued. Though it is true that some test variables overlap, the AAP’s analysis is more individuated and focuses on the goals of the tests and their relationship to establishing a reliable and meaningful exam. As the AAP concluded, “no reasonable substitutes” exist for important parts of the Settlement’s evaluative exams, the doctor's methods did not provide internal indicia of validity in the way that the Settlement requires, and the doctor paid no attention to qualitative evidence of validity through the Slick criteria.

Neuropsychological Testing: Slick Criteria and Validity Testing
October 21, 2020
The Special Master explained that where a particular Slick criterion is inconsistent or discrepant, or criteria point in different directions, the examiner must thoroughly explain in writing why the testing was valid and directed that the Claims Administrator try to obtain an analysis of the test validity that must: (1) describe why the MAF Physician believes that each Slick criteria is not a concern, focusing on the discrepancies identified by the AAP Reviewers; and (2) come to a fresh holistic judgment noting when possible why particular discrepancies should not compel a finding that the testing was invalid. The AAP should defer to a clinician’s Slick-criteria-based validity analysis when it results from reasoning completely articulated in contemporaneous reports, unless the analysis is clearly erroneous. Conversely, when clinicians fail to articulate their judgment through complete Slick analyses, the AAP may thoroughly and independently assure themselves the criteria do not indicate invalid testing. The Claims Administrator evaluates the submitted claim and determines whether it satisfies the Settlement requirements, guided by the AAP, whose job it is to make sure that claim adjudication follows the medicine.

Neuropsychological Testing and Validity
September 29, 2020
The Player submitted three sets of neuropsychological tests to support his claim based on Level 1.5 Neurocognitive Impairment.  The first was performed by a doctor whose testing has been disallowed by the Settlement Program and the second was performed more than a year before the MAF exam, so neither of those tests could be considered.  Both the neuropsychologist and the AAP determined that the third test was invalid because of suboptimal scores on performance validity tests and issues relating to several Slick criteria. Rule 10(d) of the Rules Governing MAF Physicians clarifies the proper practice for the diagnosing physician in the event that he/she disagrees with the conclusions of the examining neuropsychologist. It does not state that the Claims Administrator must simply defer to the opinion of the MAF Physician in the face of such a disagreement. Invalid neuropsychological test results cannot support a Level 1.5 Qualifying Diagnosis.

Evidence to Support a Qualifying Diagnosis
September 5, 2020
Contemporaneous proof of each listed Claim must be evaluated on its own terms, paying attention to the actual evidence before the diagnosing physician and the Claims Administrator.  Diagnosing Physicians for pre-Effective Claims do not have plenary authority to determine whether the Claimant's evidence of functional impairment was sufficient.

Demographic Norm Adjustments
August 20, 2020
Clinicians evaluating self-identified African American players may identify those players by that race and apply the full demographic adjustments under the ACS software and apply African American Heaton norm adjustments. But failure to do so is not itself a reason to deny a claim. The most that we can say is that in general both such adjustments are presently recommended. Clinicians’ discretion to adjust regarding racial norming has wide but appreciable limits. First, since full demographic adjustments are presently generally recommended, when a clinician does not use them, it is reasonable to require that the clinician explain why. The Claims Administrator may fairly worry that the clinician decided to adjust, or not, as a way of achieving a financial result for a particular player, instead of as an exercise of medical judgment. Thus, the Claims Administrator may require clinicians to show that their decision to avoid the recommendation was consistent with their ordinary practice.

Validity Testing and Cause of Functional Impairment
August 19, 2020
The Settlement explicitly addresses performance validity in two ways. First, clinicians must include performance validity tests—both embedded and standalone—in the neuropsychological test battery. These tests aim to provide a quantitative basis for detecting suboptimal effort or deliberate underperformance. Second, clinicians must evaluate performance validity by completing the Slick et al . checklist of validity criteria. As these are independent requirements, passing at least two of the performance validity tests included in the neuropsychological test battery does not end the validity analysis. In other words, as is evident from the Slick criteria, there are instances in which a patient will obtain “passing” scores across all performance validity tests, but the clinician might nonetheless determine that his neuropsychological test results are invalid.

Neuropsychologist Qualifications
August 12, 2020
The neuropsychologist was not certified by the American Board of Professional Psychology (ABPP) or the American Board of Clinical Neuropsychology (ABCN), a member board of the American Board of Professional Psychology, in the specialty of Clinical Neuropsychology and therefore the Diagnosis did not satisfy the Settlement’s requirements.

Neuropsychological Testing Not Generally Consistent
August 11, 2020
The Qualifying Diagnosis of Level 1.5 Neurocognitive Impairment on 6/3/16 was not made in a manner generally consistent with the Settlement criteria, because the neuropsychological test results reflect evidence of moderate cognitive decline in only one cognitive domain instead of two or more domains.

Stroke Definition
July 15, 2020
The Settlement Agreement directs that the word Stroke is a Term of Art, defined by the ICD 9/10. This Player suffered an emergent manifestation of cerebrovascular disease, i.e., intracranial hemorrhage, I60.7 in the ICD-10, and between 430-432 in the ICD-9.

CTE Diagnosis
July 15, 2020
The claim was denied based upon a lack of proof that the diagnosis was timely. There is no evidence that the diagnosis of Death with CTE was obtained before the appropriate deadline. Second, the claim was denied for failure of the diagnosing physician to personally examine the Player’s brain tissue. However, the evidence suggests that doctor did examine the brain tissue as is necessary to diagnose Death with CTE. The Claims Administrator correctly concluded that the Representative Claimant failed to show that the diagnosis was obtained before the appropriate deadline. The Special Master affirms the denial solely on the first basis.

CTE Diagnosis
July 15, 2020
The doctor did not examine brain tissue as is necessary to diagnose Death with CTE, and there is no proof that the diagnosis was timely. The Representative Claimant meets neither of the two Settlement requirements for a diagnosis of Death with CTE.

Pre-Diagnosis Evidence
July 2, 2020
External evidence—and, in particular, proof out of temporal joint with the diagnosis—must be evaluated with care. All three criteria focus on the claimant’s degree of impairment and function as of the time of the diagnosis, not his past behavior or his future course. Thus, the Special Master’s focus must be on the strength of the clinician’s contemporaneously created record and the Claims Administrator’s process for reviewing that record.

Validity Testing for Level 1.5 Neurocognitive Impairment Claim
June 24, 2020
Highlights that to ensure equity across Settlement Class Members, claimants must follow a standardized process that requires valid neuropsychological test results to measure cognitive performance, and the AAP and AAP Consultants who are empowered to advise on neuropsychological testing may find a Player's test results invalid

Qualified MAF Physician's Certification that Testing is Medically Unnecessary
June 8, 2020
Further elaborates on the Claims Administrator’s obligation to determine if the physician’s certification was “reasonably determined,” meaning that the physician’s choices are cognizable as an application of the Settlement’s narrow (“unless”) exception to the testing requirement (i.e., that the impairment was “so severe” that testing is “medically unnecessary”)

Post-Diagnosis Evidence
June 8, 2020
Explains that the appropriate focus on appeal is on the strength of the clinician’s contemporaneously created record and the Claims Administrator’s process for reviewing that record and that the clinical judgments resulting from that consideration ought not be undermined by later-arriving evidence that, while suggestive, fails to constitute a pattern inconsistent with the assigned CDR Rating

Generally Consistent Standard Between Level 1.5 and Level 2.0
June 2, 2020
Explains that the notion of “general consistency” does not provide the diagnosing physician latitude to loosely construe the Injury Definitions that have been set forth in the Settlement Agreement, at least without further explanation

Qualified MAF Physician's Certification that Testing is Medically Unnecessary
May 27, 2020
Discusses the Claims Administrator’s obligation to determine if the physician’s certification was “reasonably determined,” meaning that the physician’s choices are cognizable as an application of the Settlement’s narrow (“unless”) exception to the testing requirement (i.e., that the impairment was “so severe” that testing is “medically unnecessary”)

Clinical Judgment on Generally Consistent Standard
May 27, 2020
Directs that the Claims Administrator may defer to the judgment of the treating physician, and reliance should be the customary response to articulated medical judgments

Test of Premorbid Functioning (TOPF)
May 1, 2020
Discusses the use of the TOPF models to determine pre-morbid IQ

Generally Consistent (Level 2)
October 24, 2018
Discusses application of the “generally consistent” standard to a Level 2 Neurocognitive Impairment diagnosis

Appeal Decisions on Application of Generally Consistent to Facts
October 18, 2018
Clarifies the burden of proof for an appeal on “generally consistent” grounds and classifies Special Master decisions on the application of “generally consistent” to facts as factual determinations not subject to further appeal

AAP/AAPC Consultation by Special Masters
September 28, 2018
Explains that the Special Master is not required to consult with the AAP or AAPC when deciding appeals involving medical questions

Generally Consistent (Level 1.5)
September 24, 2018
Discusses timeliness of appeals and application of the “generally consistent” standard to a Level 1.5 Neurocognitive Impairment diagnosis

53-Man Active Roster
December 4, 2017
Holds that Retired NFL Football Players who were on a Member Club’s Active List (sometimes called the “53-man roster”) on the calendar day of a regular season or postseason game receive credit for that game towards an Eligible Season, even when the Player was placed on the inactive or injured reserve list before the start of the game